Luo Nan, Chew Ling-Huo, Fong Kok-Yong, Koh Dow-Rhoon, Ng Swee-Cheng, Yoon Kam-Hon, Vasoo Sheila, Li Shu-Chuen, Thumboo Julian
Department of Pharmacy, National University of Singapore, Singapore.
J Rheumatol. 2003 Oct;30(10):2268-74.
To compare the performance of 2 commonly used utility-based health-related quality of life (HRQoL) instruments [the EuroQol-5D (EQ-5D) and Health Utilities Index mark 3 (HUI3)] in patients with rheumatic disease.
Consecutive outpatients with rheumatic diseases were interviewed twice within 2 weeks using a standard questionnaire containing the EQ-5D, HUI3, and the Medical Outcome Study Short-Form 36 Health Survey (SF-36, used to categorize health status) and assessing clinical and demographic characteristics. EQ-5D and HUI3 utility scores were compared and their construct validity and test-retest reliability were examined by comparing these scores in groups differing in health status and using intraclass correlation coefficients (ICC), respectively.
EQ-5D and HUI3 utility scores in 114 patients differentiated well between varying health states; e.g., patients with higher SF-36 vitality scores had better EQ-5D and HUI3 utility scores (mean: 0.79 for both instruments) than patients with lower vitality scores (mean: 0.68 and 0.69, respectively) (p < 0.01 for both comparisons). ICC values for the EQ-5D and HUI3 were 0.64 and 0.75, respectively (n = 90, median interval: 7 days). EQ-5D and HUI3 utility scores were similar (mean +/- SD: 0.75 +/- 0.21 vs 0.76 +/- 0.17, p = 0.647, paired t test) and showed moderate correlation (Spearman's r: 0.45, p < 0.001). Differences were present in patients' responses to these 2 instruments: e.g., 12 patients reporting no problems with mobility (EQ-5D item) reported different levels of disability with ambulation (HUI3 item).
The EQ-5D and HUI3 performed equally well in measuring utility-based HRQoL in patients with rheumatic disease, although they measured slightly different, though related, dimensions of health.
比较两种常用的基于效用的健康相关生活质量(HRQoL)工具[欧洲五维健康量表(EQ-5D)和健康效用指数第3版(HUI3)]在风湿性疾病患者中的表现。
连续的风湿性疾病门诊患者在2周内接受两次访谈,使用包含EQ-5D、HUI3和医学结局研究简明健康调查(SF-36,用于分类健康状况)的标准问卷,并评估临床和人口统计学特征。比较EQ-5D和HUI3的效用得分,并通过比较不同健康状况组的得分,分别使用组内相关系数(ICC)来检验它们的结构效度和重测信度。
114例患者的EQ-5D和HUI3效用得分在不同健康状态之间有良好区分;例如,SF-36活力得分较高的患者,其EQ-5D和HUI3效用得分(两种工具的平均值均为0.79)高于活力得分较低的患者(分别为0.68和0.69)(两次比较的p均<0.01)。EQ-5D和HUI3的ICC值分别为0.64和0.75(n = 90,中位间隔:7天)。EQ-5D和HUI3效用得分相似(平均值±标准差:0.75±0.21对0.76±0.17,p = 0.647,配对t检验),且显示出中度相关性(Spearman相关系数r:0.45,p < 0.001)。患者对这两种工具的反应存在差异;例如,12名报告行动能力无问题(EQ-5D项目)的患者报告了不同程度的行走残疾(HUI3项目)。
EQ-5D和HUI3在测量风湿性疾病患者基于效用的HRQoL方面表现同样良好,尽管它们测量的是略有不同但相关的健康维度。